# Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma

> **NCT04797884** · PHASE2,PHASE3 · UNKNOWN · sponsor: **THERABIONIC INC.** · enrollment: 166 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** TheraBionic Device
- **DEVICE:** Placebo Device
- **DEVICE:** Quality of Life Assessment

## Key facts

- **NCT ID:** NCT04797884
- **Lead sponsor:** THERABIONIC INC.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07
- **Primary completion:** 2024-10-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 166 (ESTIMATED)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04797884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04797884, "Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04797884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*